Older adults with long-duration type 1 diabetes (T1D) can have additional health challenges to those experienced by...

Treatment Induced Neuropathy of Diabetes (TIND), also known as insulin neuritis, was first described in...

Glucocorticoids are an effective anti-inflammatory and immunosuppressant used in the treatment of many medical conditions, including COVID-19.  The use...

Osteoporosis is a systemic condition in which low bone mass and impairments in bone microstructure leads to increased skeletal fragility and a...

“There is a very important role for face-to-face [care], but equally that supplementary role for telehealth can give people access when they need...

Shanshan (Shannon) Lin is a member of the ADE Editorial Advisory Group, the Course Coordinator of the ADEA accredited Diabetes Education and Management...

In our first edition of the ADE for 2022 we have articles covering a wide variety of topics relevant to our work as diabetes educators.

A joint position statement has been published from a collaboration of ADEA, ADS and Diabetes Australia.

In Australia, 1.3 million people are living with diabetes and 100,000 people are being diagnosed each year.  In addition, two million are living with...

Obesity is a major risk factor for the development of T2 Diabetes (T2D) with a 3-fold increased prevalence of diabetes...